Potential adverse effects of long-term testosterone therapy

Anderson, 1992, The effects of exogenous testosterone on sexuality and mood of normal men, Journal of Clinical Endocrinology and Metabolism, 75, 1503, 10.1210/jc.75.6.1503

Anderson, 1995, Haemostatic effects of supraphysiological levels of testosterone in normal men, Thrombosis and Haemostasis, 74, 693, 10.1055/s-0038-1649799

Bagatell, 1996, Androgens in men-uses and abuses, New England Journal of Medicine, 334, 707, 10.1056/NEJM199603143341107

Bagatell, 1994, Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men, Journal of Clinical Endocrinology and Metabolism, 79, 561, 10.1210/jc.79.2.561

Barrett-Connor, 1991, Estrogen and coronary heart disease in women, Journal of the American Medical Association, 265, 1861, 10.1001/jama.1991.03460140089033

Behre, 1994, Prostate volume in testosterone-treated and untreated hypogonadal men in comparision to age-matched normal controls, Clinical Endocrinology, 40, 341, 10.1111/j.1365-2265.1994.tb03929.x

Behre, 1997, Long-term effect of testosterone therapy on bone mineral density in hypogonadal men, Journal of Clinical Endocrinology and Metabolism, 82, 2386, 10.1210/jc.82.8.2386

Bhasin, 1998, Androgens and muscles, 209

Brämswig, 1984, Pituitary-gonadal function in boys after high dose testosterone treatment for excessively tall stature, Acta Endocrinologica, 107, 97, 10.1530/acta.0.1070097

Brämswig, 1981, Testosterone-Therapie hochwüchsiger Jungen, Deutsche Medizinische Wochenschrift, 106, 1656, 10.1055/s-2008-1070573

Brown, 1995, A double blind, placebo controlled study of the effects of low dose testosterone undecanoate on the growth of small for age, prepubertal boys, Archives of Diseases of Childhood, 73, 131, 10.1136/adc.73.2.131

Buckley, 1988, Estimated prevalence of anabolic steroid use among male high school seniors, Journal of the American Medical Association, 260, 3441, 10.1001/jama.1988.03410230059028

Butler, 1992, Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth, Journal of Clinical Endocrinology and Metabolism, 75, 37, 10.1210/jc.75.1.37

Christiansen, 1998, Psychotropic effects of androgens, 107

Conway, 1988, Randomized clinical trial of testosterone replacement therapy in hypogonadal men, International Journal of Andrology, 11, 247, 10.1111/j.1365-2605.1988.tb00999.x

Demark-Wahnefried, 1997, Serum androgens: associations with prostate cancer risk and hair patterning, Journal of Andrology, 18, 495, 10.1002/j.1939-4640.1997.tb01964.x

Ebling, 1997, Development of prostate cancer after pituitary dysfunction: a report of 8 patients, Urology, 49, 564, 10.1016/S0090-4295(96)00541-9

Eckardstein, 1998, Androgens, cardiovascular risk factors, and atherosclerosis, 229

Eckardstein, 1997, Suppression of endogenous testosterone in young men increases serum levels of HDL-subclass LpA-I and lipoprotein(a), Journal of Clinical Endocrinology and Metabolism, 82, 3367, 10.1210/jc.82.10.3367

Endres, 1987, Priapism in Fabry's disease during testosterone treatment, Klinische Wochenschrift, 65, 925, 10.1007/BF01745504

Frick, 1998, Androgens and the prostate, 259

Fritz, 1984, Prenatal and postnatal development of rats following the maternal treatment with testosterone during the late period of embryogenesis, Arzneimittelforschung, 34, 780

Gooren, 1994, A ten-year safety study of the oral androgen testosterone undecanoate, Journal of Andrology, 15, 212, 10.1002/j.1939-4640.1994.tb00433.x

Gregory, 1992, Effects of oral testosterone undecanoate on growth, body composition, strength and energy expenditure of adolescent boys, Clinical Endocrinology, 37, 207, 10.1111/j.1365-2265.1992.tb02312.x

Griffin, 1992, Disorders of the testes and the male reproductive tract, 799

Hajjar, 1997, Outcome of long term testosterone replacement in older hypogonadal males: a retrospective analysis, Journal of Clinical Endocrinology and Metabolism, 82, 3793, 10.1210/jc.82.11.3793

Holmäng, 1993, Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men, Prostate, 23, 99, 10.1002/pros.2990230203

Jackson, 1989, Prostatic complications of testosterone replacement therapy, Archives of Internal Medicine, 149, 2365, 10.1001/archinte.1989.00390100157033

Jin, 1996, The effects of chronic high dose androgen or estrogen treatment on the human prostate, Journal of Clinical Endocrinology and Metabolism, 81, 4290, 10.1210/jc.81.12.4290

Ketchel, 1977, Available clinical data concerning effects of androgen treatment of men on outcome of subsequent pregnancies, 341

Knuth, 1989, Anabolic steroids and semen parameters in bodybuilders, Fertility and Sterility, 52, 1041, 10.1016/S0015-0282(16)53172-0

Leifke, 1998, Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men, European Journal of Endocrinology, 138, 51, 10.1530/eje.0.1380051

Lemcke, 1996, Long-term effects on testicular function of high-dose testosterone treatment for excessively tall stature, Journal of Clinical Endocrinology and Metabolism, 81, 296, 10.1210/jc.81.1.296

Mackey, 1995, Tolerability of intramuscular injections of testosterone ester in oil vehicle, Human Reproduction, 10, 862, 10.1093/oxfordjournals.humrep.a136051

Marin, 1992, The effects of testosterone treatment on body composition and metabolism in middle-aged obese men, International Journal of Obesity, 16, 991

Matsumoto, 1985, Testosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives, and sleep, Clinical Endocrinology, 22, 713, 10.1111/j.1365-2265.1985.tb00161.x

Meikle, 1998, A permeation-enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadism, 369

Nagelberg, 1986, Cerebrovascular accident associated with testosterone therapy in a 21-year-old hypogonadal man, New England Journal of Medicine, 314, 649, 10.1056/NEJM198603063141017

Nieschlag, 1992, Testosteron, Anabolika und aggressives Verhalten bei Männern, Deutsches Arzteblatt, 89, 2967

Nieschlag, 1996, Testosterone replacement therapy: something old, something new …, Clinical Endocrinology, 45, 261, 10.1046/j.1365-2265.1996.00823.x

Nieschlag, 1997, Testosterone therapy, 297

Nieschlag, 1998, Pharmacology and clinical use of testosterone, 293

O'Carroll, 1985, Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose, Clinical Endocrinology, 23, 527, 10.1111/j.1365-2265.1985.tb01113.x

Phillips, 1994, The association of hypotestosteronemia with coronary artery disease in men, Arteriosclerosis and Thrombosis, 14, 701, 10.1161/01.ATV.14.5.701

Randall, 1998, Androgens and hair, 169

Robaire, 1984, Suppression of spermatogenesis by testosterone in adult male rats: effect on fertility, pregnancy outcome and progeny, Biology of Reproduction, 31, 221, 10.1095/biolreprod31.2.221

Roberts, 1986, Adenocarcinoma of prostate in 40 year old body builder, Lancet, ii, 742, 10.1016/S0140-6736(86)90251-5

Rolf, 1997, Senescence, 395

Ruch, 1989, Priapism following testosterone administration for delayed male puberty, American Journal of Medicine, 86, 256, 10.1016/0002-9343(89)90286-6

Sands, 1995, Exogenous androgens in postmenopausal women, American Journal of Medicine, 98, 76S, 10.1016/S0002-9343(99)80062-X

Schiffmann, 1985, Morphological transformation of Syrian hamster embryo fibroblasts by the anabolic agent trenbolone, Archives of Toxicology, 58, 59, 10.1007/BF00292619

Shahidi, 1973, Androgens and erythropoiesis, New England Journal of Medicine, 289, 72, 10.1056/NEJM197307122890205

Sih, 1997, Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial, Journal of Clinical Endocrinology and Metabolism, 82, 1661, 10.1210/jc.82.6.1661

Stewart, 1992, Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea, American Review of Respiratory Diseases, 14, 1389, 10.1164/ajrccm/146.6.1389

Thompson, 1989, Contrasting effects of testosterone and stanazolol on serum lipoprotein levels, Journal of the American Medical Association, 261, 1165, 10.1001/jama.1989.03420080085036

Wilson, 1988, Androgen abuse by athletes, Endocrine Review, 9, 181, 10.1210/edrv-9-2-181

Winkler, 1996, Effects of androgens on haemostasis, Maturitas, 24, 147, 10.1016/S0378-5122(96)82004-4

World Health Organization, 1992

World Health Organization, 1990, Contraceptive efficacy of testosterone-induced azoospermia in normal men, Lancet, ii, 955

World Health Organization, 1995, Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies, International Journal of Andrology, 18, 157, 10.1111/j.1365-2605.1995.tb00405.x

Wu, 1996, Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study, Fertility and Sterility, 65, 626, 10.1016/S0015-0282(16)58166-7

Wu, 1993, Therapeutic effect of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients, Chinese Medical Journal, 106, 415

Young, 1993, Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception, Journal of Clinical Endocrinology and Metabolism, 77, 1028, 10.1210/jc.77.4.1028

Zelissen, 1988, Severe priapism as a complication of testosterone substitution therapy, American Journal of Medicine, 85, 273, 10.1016/S0002-9343(88)80364-4

Zgliczynski, 1996, Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men, Atherosclerosis, 121, 35, 10.1016/0021-9150(95)05673-4